Trial Profile
Evaluating Pharmacokinetics of Ledipasvir in HCV-Uninfected patients with Moderate and Severe Hepatic Impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Vedroprevir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 17 Dec 2015 New trial record